Vocalis Health is an Israel based AI healthtech company that says it has developed a new software that can analyse a person's voice and use that to detect if they have COVID 19 or not. According to the company, vocal biomarkers from people's recorded voices can be used to screen, detect, monitor and predict health symptoms, conditions and diseases. Vocalis Health is currently focused on screening users for COVID-19 and on monitoring patients with chronic diseases such as Chronic Obstructive Pulmonary Disease, Congestive Heart Failure, and Pulmonary Hypertension. The company shared the results of a study it carried out last month in Mumbai, to test its tool VocalisCheck. According to Vocalis, the study covered over 2,000 participants who spoke in multiple languages including English, Hindi, Marahi, and Gujarati.

An artificial intelligence voice analysis tool can help diagnose COVID-19 in asymptomatic patients, according to its manufacturer, Vocalis Health. The technology -- called VocalisCheck -- works by comparing a person's voice sample to a COVID-19-positive voice composite. VocalisCheck assesses their risk level of testing positive for COVID-19 and whether they require further testing. According to the company, early study results show that VocalisCheck had a sensitivity of 87% and specificity of of 53%, when used alone, adding "even better" results were achieved when combined with a symptom questionnaire. "Over time, we will collect more and more data, which can strengthen the AI and make the vocal biomarker even more accurate," Shady Hassan, MD, co‐founder, chief medical and chief operating officer of Vocalis Health, told Healio Primary Care.